Completed PHASE2 INTERVENTIONAL 1-arm NCT03509025

Follow-up Study for Participants Jointstem Clinical Trial

Open, Multicenter Follow-up Trial About Active Group of Phase IIb Clinical Trial of JOINTSTEM in Patients With Degenerative Arthritis

Sponsor: R-Bio

Conditions Knee Osteoarthritis

Interventions Jointstem

Updated 10 times since 2018 Last updated: Sep 26, 2022 Started: Feb 8, 2017 Primary completion: Dec 9, 2020 Completion: Dec 9, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Knee Osteoarthritis and is currently completed. R-Bio leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2022 — Jul 2024 [monthly]

Completed PHASE2
Feb 2021 — Sep 2022 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed

▶ Show 5 earlier versions

Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting PHASE2
Jun 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE2
Jul 2019 — Jun 2020 [monthly]

Active Not Recruiting PHASE2
Jun 2018 — Jul 2019 [monthly]

Active Not Recruiting PHASE2
May 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE2

First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

R-Bio

Data source: R-Bio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea